Lung Cancer

May 29-June 2, 2015; Chicago, Illinois
In this downloadable slideset of lung cancer clinical trial highlights from the 2015 American Society of Clinical Oncology annual meeting, Naiyer Rizvi, MD, and Heather Wakelee, MD, discuss key immunotherapy studies in NSCLC and SCLC, review targeting of driver mutations, and discuss treatment of mesothelioma.
Format: Microsoft PowerPoint (.ppt)
File Size: 2.36 MB
Released: August 7, 2015

Acknowledgements

Educational grant provided by:
AstraZeneca
Bayer HealthCare Pharmaceuticals Inc.
Bristol-Myers Squibb
Celgene Corporation
Genentech BioOncology
Incyte
Novartis Pharmaceuticals Corporation

Related Content

EHR data analysis from ASCO 2021 showed that NGS testing and clinical trial participation were less likely among Black patients with NSCLC than White patients, as reported by Clinical Care Options (CCO)

Released: June 15, 2021

Download these expert-selected slides on testing for TRK fusions in your patients with cancer, from Clinical Care Options (CCO).

George D. Demetri, MD Released: June 11, 2021

Download these expert-selected slides on slides on treating patients with NTRK-positive tumors with TRK inhibitors, from Clinical Care Options (CCO).

Alexander Drilon, MD Released: June 11, 2021

Download these expert-selected slides on slides on overcoming acquired resistance with TRK inhibitors, from Clinical Care Options (CCO).

Theodore Laetsch, MD Released: June 11, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue